Efficient SIVcpz replication in human lymphoid tissue requires viral matrix protein adaptation

Journal of Clinical Investigation

Volumn 122, Issue 5, 2012, Pages 1644-1652

  Bibollet Ruche, Frederic ^a   Heigele, Anke ^b   Keele, Brandon F ^c   Easlick, Juliet L ^d   Decker, Julie M ^d   Takehisa, Jun ^d   Learn, Gerald ^d   Sharp, Paul M ^e   Hahn, Beatrice H ^a   Kirchhoff, Frank ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY HOSPITAL ULM   (Germany)

^c SAIC FREDERICK INC   (United States)

^d University of Alabama at Birmingham   (United States)

^e UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; LYSINE; MATRIX PROTEIN;

ADAPTATION; ANIMAL CELL; ARTICLE; CD4+ T LYMPHOCYTE; CHIMPANZEE; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN TISSUE; IN VIVO STUDY; LYMPHOID TISSUE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS REPLICATION; VIRUS STRAIN;

ADAPTATION, BIOLOGICAL; AMINO ACID SUBSTITUTION; ANIMALS; CELLS, CULTURED; GENE PRODUCTS, GAG; HIV-1; HOST-PATHOGEN INTERACTIONS; HUMANS; LENTIVIRUS INFECTIONS; MUTAGENESIS, SITE-DIRECTED; PALATINE TONSIL; PAN TROGLODYTES; PHYLOGENY; SIMIAN IMMUNODEFICIENCY VIRUS; TISSUE CULTURE TECHNIQUES; VIRAL MATRIX PROTEINS; VIRUS REPLICATION;

EID: 84860559055     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI61429     Document Type: Article

References (61)

1. Sharp PM, Hahn BH. Origins of HIV and the AIDS pandemic. Cold Spring Harb Perspect Med. 2011;1(1):a006841.
2. Van Heuverswyn F, et al. SIV infection in wild gorillas. Nature. 2006;444(7116):164.
3. Keele BF, et al. Chimpanzee reservoirs of pandemic and nonpandemic HIV-1. Science. 2006;313(5786):523-526. (Pubitemid 44148457)
4. Plantier JC, et al. A new human immunodeficiency virus derived from gorillas. Nat Med. 2009;15(8):871-872.
5. Vallari A, et al. Confirmation of putative HIV-1 group P in Cameroon. J Virol. 2011;85(3):1403-1407.
6. Takehisa J, et al. Origin and biology of simian immunodeficiency virus in wild-living western gorillas. J Virol. 2009;83(4):1635-1648.
7. Mauclere P, et al. Serological and virological characterization of HIV-1 group O infection in Cameroon. AIDS. 1997;11(4):445-453. (Pubitemid 27113005)
8. Peeters M, et al. Geographical distribution of HIV-1 group O viruses in Africa. AIDS. 1997;11(4):493-498. (Pubitemid 27113011)
9. Vallari A, et al. Four new HIV-1 group N isolates from Cameroon: Prevalence continues to be low. AIDS Res Hum Retroviruses. 2010;26(1):109-115.
10. Delaugerre C, De Oliveira F, Lascoux-Combe C, Plantier J-C, Simon F. HIV-1 group N: travelling beyond Cameroon. Lancet. 2011;378(9806):1894.
11. Kirchhoff F. Immune evasion and counteraction of restriction factors by HIV-1 and other primate lentiviruses. Cell Host Microbe. 2010;8(1):55-67.
12. Bushman FD, et al. Host cell factors in HIV replication: meta-analysis of genome-wide studies. PLoS Pathog. 2009;5(5):e1000437.
13. Ortiz M, Bleiber G, Martinez R, Kaessmann H, Telenti A. Patterns of evolution of host proteins involved in retroviral pathogenesis. Retrovirology. 2006;3:11.
14. Longdon B, Hadfield JD, Webster CL, Obbard DJ, Jiggins FM. Host phylogeny determines viral persistence and replication in novel hosts. PLoS Pathog. 2011;7(9):e1002260.
15. Streicker DG, Turmelle AS, Vonhof MJ, Kuzmin IV, McCracken GF, Rupprecht CE. Host phylogeny constrains cross-species emergence and establishment of rabies virus in bats. Science. 2010;329(5992):676-679.
16. The Chimpanzee Sequencing and Analysis Consortium. Initial sequence of the chimpanzee genome and comparison with the human genome. Nature. 2005;437(7055):69-87.
17. McLean CY, et al. Human-specific loss of regulatory DNA and the evolution of human-specific traits. Nature. 2011;471(7337):216-219.
18. Wain LV, et al. Adaptation of HIV-1 to its human host. Mol Biol Evol. 2007;24(8):1853-1860. (Pubitemid 47236708)
19. Mwaengo DM, Novembre FJ. Molecular cloning and characterization of viruses isolated from chimpanzees with pathogenic human immunodeficiency virus type 1 infections. J Virol. 1998;72(11):8976-8987. (Pubitemid 28471842)
20. Glushakova S, Baibakov B, Margolis LB, Zimmerberg J. Infection of human tonsil histocultures: a model for HIV pathogenesis. Nat Med. 1995;1(12):1320-1322.
21. Glushakova S, et al. Nef enhances human immunodeficiency virus replication and responsiveness to interleukin-2 in human lymphoid tissue ex vivo. J Virol. 1999;73(5):3968-3974. (Pubitemid 29189841)
22. Takehisa J, et al. Generation of infectious molecular clones of simian immunodeficiency virus from fecal consensus sequences of wild chimpanzees. J Virol. 2007;81(14):7463-7475. (Pubitemid 47047834)
23. Van Heuverswyn F, et al. Genetic diversity and phylogeographic clustering of SIVcpzPtt in wild chimpanzees in Cameroon. Virology. 2007;368(1):155-171.
24. Adachi A, et al. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J Virol. 1986;59(2):284-291. (Pubitemid 16013975)
25. Papkalla A, Münch J, Otto C, Kirchhoff F. Nef enhances human immunodeficiency virus type 1 infectivity and replication independently of viral coreceptor tropism. J Virol. 2002;76(16):8455-8459. (Pubitemid 34809097)
26. Ghosh SK, et al. A molecular clone of HIV-1 tropic and cytopathic for human and chimpanzee lymphocytes. Virology. 1993;194(2):858-864.
27. Li Y, Kappes JC, Conway JA, Price RW, Shaw GM, Hahn BH. Molecular characterization of human immunodeficiency virus type 1 cloned directly from uncultured human brain tissue: identification of replication-competent and -defective viral genomes J Virol. 1991;65(8):3973-3985.
28. Li Y, et al. Complete nucleotide sequence, genome organization, and biological properties of human immunodeficiency virus type 1 in vivo: evidence for limited defectiveness and complementation. J Virol. 1992;66(11):6587-6600.
29. Koyanagi Y, Miles S, Mitsuyasu RT, Merrill JE, Vinters HV, Chen IS. Dual infection of the central nervous system by AIDS viruses with distinct cellular tropisms. Science. 1987;236(4803):819-822. (Pubitemid 17071156)
30. Platt EJ, Wehrly K, Kuhmann SE, Chesebro B, Kabat D. Effects of CCR5 and CD4 cell surface concentrations on infection by macrophagetropic isolates of human immunodeficiency virus type 1. J Virol. 1998;72(4):2855-2864. (Pubitemid 28175522)
31. Wei X, et al. Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy. Antimicrob Agents Chemother. 2002;46(6):1896-1905. (Pubitemid 34535213)
32. Schoggins JW, et al. A diverse range of gene products are effectors of the type I interferon antiviral response. Nature. 2011;472(7344):481-485.
33. Bushman FD, et al. Host cell factors in HIV replication: meta-analysis of genome-wide studies. PLoS Pathog. 2009;5(5):e1000437.
34. Jäger S, et al. Global landscape of HIV-human protein complexes. Nature. 2011;481(7381):365-370.
35. Neil SJ, Zang T, Bieniasz PD. Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. Nature. 2008;451(7177):425-430. (Pubitemid 351158893)
36. Van Damme N, et al. The interferon-induced protein BST-2 restricts HIV-1 release and is downregulated from the cell surface by the viral Vpu protein. Cell Host Microbe. 2008;3(4):245-252. (Pubitemid 351494713)
37. Jia B, et al. Species-specific activity of SIV Nef and HIV-1 Vpu in overcoming restriction by tetherin/BST2. PLoS Pathog. 2009;5(5):1000429.
38. Sauter D, et al. Tetherin-driven evolution of Vpu and Nef function and the emergence of pandemic and non-pandemic HIV-1 strains. Cell Host Microbe. 2009;6(5):409-421.
39. Zhang F, et al. Nef proteins from simian immunodeficiency viruses are tetherin antagonists. Cell Host Microbe. 2009;6(1):54-67.
40. Rücker E, Grivel JC, Münch J, Kirchhoff F, Margolis L. Vpr and Vpu are important for efficient human immunodeficiency virus type 1 replication and CD4+ T-cell depletion in human lymphoid tissue ex vivo. J Virol. 2004;78(22):12689-12693. (Pubitemid 39458789)
41. Yang SJ, Lopez LA, Exline CM, Haworth KG, Cannon PM. Lack of adaptation to human tetherin in HIV-1 group O and P. Retrovirology. 2011;8:78.
42. Sauter D, et al. HIV-1 Group P is unable to antagonize human tetherin by Vpu, Env or Nef. Retrovirology. 2011;8:103.
43. Rudicell RS, et al. High prevalence of simian immunodeficiency virus infection in a community of savanna chimpanzees. J Virol. 2011;85(19):9918-9928.
44. Hearps AC, Jans DA. Regulating the functions of the HIV-1 matrix protein. AIDS Res Hum Retroviruses. 2007;23(3):341-346. (Pubitemid 46608553)
45. Bukrinskaya A. HIV-1 matrix protein: a mysterious regulator of the viral life cycle. Virus Res. 2007;124(1-2):1-11. (Pubitemid 46216552)
46. Batonick M, Favre M, Boge M, Spearman P, Honing S, Thali M. Interaction of HIV-1 Gag with the clathrin-associated adaptor AP-2. Virology. 2005;342(2):190-200. (Pubitemid 41566652)
47. Camus G, et al. The clathrin adaptor complex AP-1 binds HIV-1 and MLV Gag and facilitates their budding. Mol Biol Cell. 2007;18(8):3193-3203. (Pubitemid 47235322)
48. Dong X, et al. AP-3 directs the intracellular trafficking of HIV-1 Gag and plays a key role in particle assembly. Cell. 2005;120(5):663-174.
49. Tang Y, et al. Cellular motor protein KIF-4 associates with retroviral Gag. J Virol. 1999; 73(12):10508-10513.
50. Ghanam RH, Fernandez TF, Fledderman EL, Saad JS. Binding of calmodulin to the HIV-1 matrix protein triggers myristate exposure. J Biol Chem. 2010;285(53):41911-41920.
51. Lopez-Verges S, Camus G, Blot G, Beauvoir R, Benarous R, Berlioz-Torrent C. Tail-interacting protein TIP47 is a connector between Gag and Env and is required for Env incorporation into HIV-1 virions. Proc Natl Acad Sci U S A. 2006;103(40):14947-14952. (Pubitemid 44527834)
52. Cimarelli A, Luban J. Translation elongation factor 1-alpha interacts specifically with the human immunodeficiency virus type 1 Gag polyprotein. J Virol. 1999;73(7):5388-5401. (Pubitemid 29274821)
53. Gupta K, Ott D, Hope TJ, Siliciano RF, Boeke JD. A human nuclear shuttling protein that interacts with human immunodeficiency virus type 1 matrix is packaged into virions. J Virol. 2000;74(24):11811-11824. (Pubitemid 32222331)
54. Mansharamani M, et al. Barrier-to-autointegration factor BAF binds p55 Gag and matrix and is a host component of human immunodeficiency virus type 1 virions. J Virol. 2003;77(24):13084-13092. (Pubitemid 37494304)
55. Samelson LE. Signal transduction mediated by the T cell antigen receptor: the role of adapter proteins. Annu Rev Immunol. 2002;20:371-394. (Pubitemid 34293429)
56. Larkin MA, et al. Clustal W and Clustal X version 2.0. Bioinformatics. 2007;23(21):2947-2948. (Pubitemid 350162903)
57. Guindon S, Dufayard JF, Lefort V, Anisimova M, Hordijk W, Gascuel O. New algorithms and methods to estimate maximum-likelihood phylogenies: assessing the performance of PhyML 3.0. Syst Biol. 2010;59(3):307-321.
58. Le SQ, Gascuel O. An improved general amino acid replacement matrix. Mol Biol Evol. 2008;25(7):1307-1320. (Pubitemid 351882003)
59. Abascal F, Zardoya R, Posada D. ProtTest: selection of best-fit models of protein evolution. Bioinformatics. 2005;21(9):2104-2105. (Pubitemid 40668057)
60. Münch J, et al. Nef-mediated enhancement of virion infectivity and stimulation of viral replication are fundamental properties of primate lentiviruses. J Virol. 2007;81(24):13852-13864. (Pubitemid 350247879)
61. Decker JM, et al. Effective activation alleviates the replication block of CCR5-tropic HIV-1 in chimpanzee CD4+ lymphocytes. Virology. 2009;394(1):109-118.